Serum levels of interleukin-1 (IL-1α, IL-1β) in patients with alopecia areata
Introduction: Alopecia areata (AA) is disease characterized by focally, nonscarring hair loss on the scalp or other parts of the body. It affects 1-2% population of both genders and occurs at all age groups. The etiology is unknown, although most evidence supports the hypothesis that AA is a T-cell-...
Main Authors: | Emina Kasumagić-Halilovic, Nermina Ovcina-Kurtovic |
---|---|
Format: | Article |
Language: | English |
Published: |
Our Dermatology Online
2012-07-01
|
Series: | Nasza Dermatologia Online |
Subjects: | |
Online Access: | http://www.odermatol.com/wp-content/uploads/file/2012%203/DOI-1.pdf |
Similar Items
-
Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata,
by: Özge Aşkın, et al.
Published: (2021-10-01) -
Alopecia areata: Treatment options
by: E. Kasumagić-Halilović, et al.
Published: (2006-02-01) -
THE INVESTIGATION OF SOME CYTOKINES ROLE IN THE DEVELOPMENT OF ALOPECIA AREATA
by: Aljabali M. A., et al.
Published: (2020-12-01) -
Tumor necrosis factor-alpha in patients with alopecia areata
by: Emina Kasumagic-Halilovic, et al.
Published: (2011-01-01) -
The relationship between −330 interleukin-2 gene polymorphism and its plasma levels in patients with alopecia areata
by: Sarah Isam Al-Rubaye, et al.
Published: (2019-01-01)